Mitofusion-2-mediated alleviation of insulin resistance in rats through reduction in lipid intermediate accumulation in skeletal muscle

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Zhang, Xuemei ^a   Wang, Chao ^b   Song, Guangyao ^b   Gan, Kexin ^b   Kong, Dexian ^a   Nie, Qian ^a   Ren, Luping ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

CD36; CPT1; Insulin resistance; Lipid intermediates; Mitofusion2; Skeletal musle

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; DYNAMIN; MITOFUSION 2; UNCLASSIFIED DRUG; CARNITINE PALMITOYLTRANSFERASE; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; MITOFUSIN 2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; LIPID DIET; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; UPREGULATION; ANIMAL; GENETICS; LIPID METABOLISM; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DOWN-REGULATION; ENERGY METABOLISM; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879467595     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-45     Document Type: Article

References (32)

1. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. DeFronzo RA, Diabetes 1988 37 667 687 3289989
2. Cellular mechanisms of insulin resistance. Shulman GI, J Clin Invest 2000 106 171 176 10.1172/JCI10583 10903330 (Pubitemid 30483118)
3. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH, J Clin Invest 2007 117 1679 1689 10.1172/JCI30565 17510710 (Pubitemid 46871352)
4. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. Schenk S, Horowitz JF, J Clin Invest 2007 117 1690 1698 10.1172/JCI30566 17510709 (Pubitemid 46871353)
5. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH, Diabetes 1991 40 1397 1403 10.2337/diabetes.40.11.1397 1936601
6. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Atkinson LL, Kozak R, Kelly SE, Onay Besikci A, Russell JC, Lopaschuk GD, Am J Physiol Endocrinol Metab 2003 284 923 E930 12464581
7. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, Taegtmeyer H, Diabetes 2002 51 2587 2595 10.2337/diabetes.51.8.2587 12145175 (Pubitemid 34827411)
8. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Bruce CR, Brolin C, Turner N, Cleasby ME, van der Leij FR, Cooney GJ, Kraegen EW, Am J Physiol Endocrinol Metab 2007 292 1231 E1237 17179390
9. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI, N Engl J Med 2004 350 664 671 10.1056/NEJMoa031314 14960743 (Pubitemid 38364625)
10. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow ML, Nair KS, Diabetes 2006 55 3309 3319 10.2337/db05-1230 17130474 (Pubitemid 44923587)
11. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS, Proc Natl Acad Sci USA 2003 100 7996 8001 10.1073/pnas.1332551100 12808136 (Pubitemid 36760083)
12. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE, Diabetes 2005 54 8 14 10.2337/diabetes.54.1.8 15616005 (Pubitemid 40105089)
13. Mitochondrial dynamics in mammalian health and disease. Liesa M, Palacin M, Zorzano A, Physiol Rev 2009 89 799 845 10.1152/physrev.00030.2008 19584314
14. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, Daugaard JR, Lloberas J, Camps M, Zierath JR, Rabasa-Lhoret R, Wallberg-Henriksson H, Laville M, Palacin M, Vidal H, Rivera F, Brand M, Zorzano A, J Biol Chem 2003 278 17190 17197 10.1074/jbc.M212754200 12598526 (Pubitemid 36799599)
15. Control of mitochondrial morphology by a human mitofusin. Santel A, Fuller MT, J Cell Sci 2001 114 867 874 11181170 (Pubitemid 32266258)
16. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. Santel A, Frank S, Gaume B, Herrler M, Youle RJ, Fuller MT, J Cell Sci 2003 116 2763 2774 10.1242/jcs.00479 12759376 (Pubitemid 36857227)
17. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X, Palacin M, Zorzano A, Hum Mol Genet 2005 14 1405 1415 10.1093/hmg/ddi149 15829499 (Pubitemid 40823451)
18. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Schaffer JE, Lodish HF, Cell 1994 79 427 436 10.1016/0092-8674(94)90252-6 7954810 (Pubitemid 24346058)
19. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. McGarry JD, Brown NF, Eur J Biochem 1997 244 1 14 10.1111/j.1432-1033.1997.00001.x 9063439 (Pubitemid 27079689)
20. Muscle enzyme activity in humans: role of substrate availability and training. Helge JW, Kiens B, Am J Physiol 1997 272 1620 R1624 9176356
21. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Sebastian D, Hernandez-Alvarez MI, Segales J, Sorianello E, Munoz JP, Sala D, Waget A, Liesa M, Paz JC, Gopalacharyulu P, Oresic M, Pich S, Burcelin R, Palacin M, Zorzano A, Proc Natl Acad Sci USA 2012 109 5523 5528 10.1073/pnas.1108220109 22427360
22. Kruppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs. Zhang R, Han M, Zheng B, Li YJ, Shu YN, Wen JK, Acta Pharmacol Sin 2010 31 1293 1302 10.1038/aps.2010.96 20711222
23. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang CH, Cooney RN, Ann Surg 2009 249 277 285 10.1097/SLA. 0b013e3181904af0 19212182
24. Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro KL, Ladenheim EE, Ronnett GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH, Proc Natl Acad Sci USA 2007 104 17358 17363 10.1073/pnas.0708385104 17956983 (Pubitemid 350219847)
25. Measurement of ceramide levels by the diacylglycerol kinase reaction and by high-performance liquid chromatography-fluorescence spectrometry. Bose R, Kolesnick R, Methods Enzymol 2000 322 373 378 10914031 (Pubitemid 30482070)
26. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, Bollheimer LC, J Mol Endocrinol 2006 36 485 501 10.1677/jme.1.01909 16720718 (Pubitemid 43904942)
27. Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Chow L, From A, Seaquist E, Metabolism 2010 59 70 85 10.1016/j.metabol.2009.07.009 19766267
28. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance. Sebastian D, Herrero L, Serra D, Asins G, Hegardt FG, Am J Physiol Endocrinol Metab 2007 292 677 E686 17062841
29. Mutational analysis of action of mitochondrial fusion factor mitofusin-2. Honda S, Aihara T, Hontani M, Okubo K, Hirose S, J Cell Sci 2005 118 3153 3161 10.1242/jcs.02449 15985463 (Pubitemid 41149918)
30. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC, J Cell Biol 2003 160 189 200 10.1083/jcb.200211046 12527753 (Pubitemid 36254953)
31. Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects. Yoshizumi T, Nozaki S, Fukuchi K, Yamasaki K, Fukuchi T, Maruyama T, Tomiyama Y, Yamashita S, Nishimura T, Matsuzawa Y, J Nucl Med 2000 41 1134 1138 10914901 (Pubitemid 30463994)
32. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, Bonen A, J Biol Chem 2004 279 36235 36241 10.1074/jbc.M400566200 15161924 (Pubitemid 39128959)